Triple Therapy or Triple threat? Balancing the risks of antithrombotic therapy for patients with atrial fibrillation and coronary stents

被引：14
|
作者：
Francescone, Steven [1 ]
Halperin, Jonathan L. [1 ]
机构：
[1] Mt Sinai Hosp, Med Ctr, Cardiovasc inst, New York, NY 10029 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2008年 / 51卷 / 08期
关键词：
D O I：
10.1016/j.jacc.2007.11.034
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：826 / 827
页数：2
相关论文
共 50 条
  • [31] Antithrombotic therapy in atrial fibrillation: stop triple therapy and start optimizing dual therapy?
    Bernhard Wernly
    Michael Lichtenauer
    David Erlinge
    Christian Jung
    Clinical Research in Cardiology, 2020, 109 : 128 - 130
  • [32] Dual or triple therapy in patients with atrial fibrillation and drug-eluting stents?
    Sambola, Antonia
    Garcia-Dorado, David
    CORONARY ARTERY DISEASE, 2015, 26 (05) : 367 - 368
  • [33] Dual antithrombotic therapy is similarly effective to triple therapy in preventing thrombotic events in patients with atrial fibrillation and acute coronary syndrome
    Motovska, Z.
    Melicharova, H.
    Knot, J.
    Dusek, J.
    Simek, S. S.
    Varvarovsky, I.
    Hlinomaz, O.
    Blaha, M.
    Klika, P.
    Jarkovsky, J.
    EUROPEAN HEART JOURNAL, 2019, 40 : 2990 - 2990
  • [34] Triple therapy for all patients with atrial fibrillation undergoing coronary stenting?
    Mutuberria Urdaniz, M.
    Sambola, A.
    Bosch, E.
    Garcia Del Blanco, B.
    Alonso, A.
    Cequier, A.
    Bueno, H.
    Rodriguez, O.
    Barrabes, J. A.
    Garcia-Dorado, D.
    EUROPEAN HEART JOURNAL, 2013, 34 : 102 - 102
  • [35] Triple therapy for atrial fibrillation and percutaneous coronary intervention
    Bennaghmouch, Naoual
    Dewilde, Willem J. M.
    ten Berg, Jurrien M.
    CURRENT OPINION IN CARDIOLOGY, 2015, 30 (06) : 690 - 696
  • [36] Triple therapy for patients with stent and atrial fibrillation? No!
    Moser, M.
    Bode, C.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2013, 138 (39) : 1967 - 1967
  • [37] Duration of triple antithrombotic therapy and clinical outcomes after percutaneous coronary intervention in atrial fibrillation
    Sammut, Mark A.
    Conway, Dwayne
    Iqbal, Javaid
    Krishnamurthy, Arvindra
    Morgan, Kenneth P.
    Morris, Paul D.
    Richardson, James D.
    Rothman, Alexander M. K.
    Gunn, Julian P.
    Storey, Robert F.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2024, 22 (07) : 339 - 345
  • [38] Optimal antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary intervention: triple therapy is too much!
    Jacobs, M. S.
    Tieleman, R. G.
    NETHERLANDS HEART JOURNAL, 2018, 26 (06) : 334 - 340
  • [39] The influence of sarcopenia on bleeding risk in patients with atrial fibrillation undergoing coronary stenting and subsequent triple antithrombotic therapy
    Tsuchida, K.
    Nishida, K.
    Tanaka, K.
    Akiyama, T.
    Hakamata, T.
    Sudo, K.
    Hosaka, Y.
    Takahashi, K.
    Oda, H.
    EUROPEAN HEART JOURNAL, 2018, 39 : 454 - 455
  • [40] Correction to: Antithrombotic therapy in atrial fibrillation: stop triple therapy and start optimizing dual therapy?
    Bernhard Wernly
    Michael Lichtenauer
    David Erlinge
    Christian Jung
    Clinical Research in Cardiology, 2020, 109 : 131 - 131
12345